RSS   Newsletter   Contact   Advertise with us
Post Online Media

Therachon appoints Maarten Kraan as CMO

Maarten KraanTherachon, a biotechnology company, announced it has appointed Maarten Kraan to the role of chief medical officer.
Article continues below

READ MORE TNT Express appoints new CFO

Most recently, Dr. Kraan was Senior Vice President, Head of Innovative Medicines Respiratory and Inflammation at AstraZeneca.

Prior to that, Dr. Kraan was Vice President, Head of Clinical Research and Experimental Development Inflammation at Hoffman La Roche.

Before that, he was Vice President, Immunosciences at Bristol Myers Squibb.

Dr. Kraan began his pharmaceutical career at Schering Plough, holding roles of increasing responsibility, including Senior Global Medical Director Immunology, Global Medical Affairs.

He currently serves as an Adjunct Professor at Goteborg University (Sweden).

Dr. Kraan held numerous academic, editorial and hospital positions before entering the pharmaceutical industry.

He received his Ph.D. in immunology and M.D. from Leiden University (Netherlands).



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy